Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity
Xianchun Zhong, Yameng Liu, Xiaoxia Gao, Kristopher W. Krausz, Bing Niu, Frank J. Gonzalez, Cen Xie
Topics & Concepts
Caffeic acid phenethyl esterNonalcoholic fatty liver diseaseFarnesoid X receptorSteatosisPropolisGut floraBile acidInternal medicinePharmacologyEndocrinologyCeramideBiochemistryMedicineBiologyFatty liverCaffeic acidAntioxidantTraditional medicineDiseaseGeneTranscription factorApoptosisNuclear receptorLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseBiochemical effects in animals